Michael L. Peterson - 16 Jan 2023 Form 4 Insider Report for TRxADE HEALTH, INC (SCNX)

Role
Director
Signature
/s/ Michael L. Peterson
Issuer symbol
SCNX
Transactions as of
16 Jan 2023
Net transactions value
$0
Form type
4
Filing time
20 Jan 2023, 15:15:19 UTC
Previous filing
06 Jan 2023
Next filing
17 Feb 2023
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Michael L. Peterson filed Form 4 for TRxADE HEALTH, INC (SCNX) on 20 Jan 2023."

Quick Takeaways

  • This page summarizes Michael L. Peterson's Form 4 filing for TRxADE HEALTH, INC (SCNX).
  • 2 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 20 Jan 2023, 15:15.

What Changed

  • Previous filing in this sequence was filed on 06 Jan 2023.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEDS Common stock Award $0 +100,000 +528% $0.000000 118,940 16 Jan 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEDS Stock Option Award $0 +135,802 $0.000000 135,802 16 Jan 2023 Common Stock 135,802 $0.4050 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/8th of such shares per quarter (on the first day of each calendar quarter), with the first vesting beginning on April 1, 2023, subject to the recipient's continued service to the Issuer. Exempt pursuant to Rule 16b-3.
F2 Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer and Chairperson of the Audit Committee. Issued under the Issuer's Amended and Restated 2019 Equity Incentive Plan.
F3 The options vest at the rate of 1/2 of such options per year, on January 4, 2024 and 2025, subject to the recipient's continued service to the Issuer. Exempt pursuant to Rule 16b-3.

Sponsored